Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry

MLA

Margalida Calafat, et al. “Clinical and Treatment Outcomes of a Second Subcutaneous or Intravenous Anti-TNF in Patients with Ulcerative Colitis Treated with Two Consecutive Anti-TNF Agents: Data from the ENEIDA Registry.” Therapeutic Advances in Gastroenterology, vol. 17, Jan. 2024. EBSCOhost, https://doi.org/10.1177/17562848231221713.

APA

Margalida Calafat, Paola Torres, Joan Tosca-Cuquerella, Rubén Sánchez-Aldehuelo, Montserrat Rivero, Marisa Iborra, María González-Vivo, Isabel Vera, Luisa de Castro, Luis Bujanda, Manuel Barreiro-de Acosta, Carlos González-Muñoza, Xavier Calvet, José Manuel Benítez, Mónica Llorente-Barrio, Gerard Surís, Fiorella Cañete, Lara Arias-García, David Monfort, … Eugeni Domènech. (2024). Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry. Therapeutic Advances in Gastroenterology, 17. https://doi.org/10.1177/17562848231221713

Chicago

Margalida Calafat, Paola Torres, Joan Tosca-Cuquerella, Rubén Sánchez-Aldehuelo, Montserrat Rivero, Marisa Iborra, María González-Vivo, et al. 2024. “Clinical and Treatment Outcomes of a Second Subcutaneous or Intravenous Anti-TNF in Patients with Ulcerative Colitis Treated with Two Consecutive Anti-TNF Agents: Data from the ENEIDA Registry.” Therapeutic Advances in Gastroenterology 17 (January). doi:10.1177/17562848231221713.